HCAT241220C5000
- 3.25
- 0.000.00%
Health Catalyst Newsroom
J.P. Morgan Maintains Health Catalyst(HCAT.US) With Buy Rating, Cuts Target Price to $12
Health Catalyst (HCAT) Receives a Buy From J.P. Morgan
Health Catalyst Launches AI-Enabled Cyber Protection Product for Healthcare
Is Health Catalyst (NASDAQ:HCAT) Using Debt In A Risky Way?
Health Catalyst Is Maintained at Equal-Weight by Stephens & Co.
Stephens Maintains Health Catalyst(HCAT.US) With Hold Rating, Raises Target Price to $9
Health Catalyst Price Target Raised to $9 From $7 at Stephens
Express News | Health Catalyst Inc : Stephens Raises Target Price to $9 From $7
Health Catalyst to Participate in Upcoming Investor Conference
Citi Maintains Health Catalyst(HCAT.US) With Buy Rating, Raises Target Price to $10.5
One Health Catalyst Insider Raised Their Stake In The Previous Year
Stifel Maintains Health Catalyst(HCAT.US) With Hold Rating, Raises Target Price to $10
Health Catalyst Reports Q3 Revenue Growth Amid Reduced Losses
Health Catalyst | 10-Q: Q3 2024 Earnings Report
Health Catalyst Is Maintained at Sector Perform by RBC Capital
Health Catalyst Analyst Ratings
CCORF Maintains Health Catalyst(HCAT.US) With Buy Rating, Maintains Target Price $11
Evercore Maintains Health Catalyst(HCAT.US) With Buy Rating, Maintains Target Price $10
RBC Capital Maintains Health Catalyst(HCAT.US) With Hold Rating, Raises Target Price to $9
BTIG Maintains Health Catalyst(HCAT.US) With Buy Rating, Maintains Target Price $13